Found: 18
Select item for more details and to access through your institution.
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1270, n. 1, p. 8, doi. 10.1111/j.1749-6632.2012.06757.x
- By:
- Publication type:
- Article
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1547, doi. 10.1007/s00262-019-02383-z
- By:
- Publication type:
- Article
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 999, doi. 10.1007/s00262-015-1704-6
- By:
- Publication type:
- Article
Armed antibodies for cancer treatment: a promising tool in a changing era.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 113, doi. 10.1007/s00262-014-1621-0
- By:
- Publication type:
- Article
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1021, doi. 10.1007/s00262-013-1418-6
- By:
- Publication type:
- Article
Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 605, doi. 10.1007/s00262-012-1365-7
- By:
- Publication type:
- Article
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 41, doi. 10.1007/s00262-011-1089-0
- By:
- Publication type:
- Article
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy).
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 467, doi. 10.1007/s00262-010-0958-2
- By:
- Publication type:
- Article
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1297, doi. 10.1007/s00262-008-0642-y
- By:
- Publication type:
- Article
Eruptive porokeratosis under nivolumab adjuvant treatment for melanoma.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
False Leser–Trélat sign.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 361, doi. 10.3390/cancers12020361
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-82
- By:
- Publication type:
- Article
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 56, doi. 10.1186/1479-5876-8-56
- By:
- Publication type:
- Article
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab.
- Published in:
- Endocrine (1355008X), 2017, v. 58, n. 3, p. 535, doi. 10.1007/s12020-017-1289-2
- By:
- Publication type:
- Article
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications.
- Published in:
- Journal of Cellular Physiology, 2011, v. 226, n. 10, p. 2595, doi. 10.1002/jcp.22600
- By:
- Publication type:
- Article
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 352, doi. 10.1002/jcp.22040
- By:
- Publication type:
- Article
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
- Published in:
- Molecular Oncology, 2011, v. 5, n. 2, p. 164, doi. 10.1016/j.molonc.2011.02.001
- By:
- Publication type:
- Article